Published: Nov-2022|  Format: PDF | MBI Research |  Number of pages: 140 | Code: MBI-3929536

Microfluidics Market Size, Share, Growth & Demand Analysis Report By Material (Glass, Silicone, Polymer, and Others) By Product (Flow and pressure sensors, Micropumps, Microneedles, Microfluidic chips and Other components) By (Pharmaceutical and Biotechnology research, Drug delivery systems, Point-of-Care Testing (POCT) diagnostics, Clinical Diagnostics, and Other) Forecast Period 2022-2030

Select a Format




 Buy Now

Market Overview:

The Global Microfluidics Market size was valued at USD 19.15 billion in 2021 and is projected to register a valuation of USD 61 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 15.8% over the forecast period 2022-2030. Increasing technological advances in the field of microfluidics such as vitro diagnostic (IVD), point-of-care testing (POCT), several investments in research and development activities, rising demand for microfluidic platforms for early disease detection and pathogen identification at the same time growing applications of microfluidic platforms in the healthcare sector are the major factors driving the market revenue growth.

Point-of-care testing allows healthcare professionals to diagnose a patient in an ambulance, doctor's office, hospital, field, or at home. Microfluidic technology-assisted devices are currently deployed for point-of-care testing because of their small sample volume requirement and they use channels that are micro-fabricated for the analysis of samples.

Microfluidics is fastest gaining traction in a variety of fields including therapeutics, chemical synthesis, biosensing, biomedical, drug discovery, pharmaceutical, immunology, and others, aiding in its transition from a potential research and development tool to a commercially viable technology. A focus on automation and greater functionality through the integration of complex electrical controls, mechanical features, in-situ sensing, and flow control is driving the revenue growth of the microfluidics market.

The increasing production of new manufacturing technologies such as 3-D printing is projected to lead to easier access to more innovative strategies for manufacturing future microfluidic devices. This will result in less expensive, more integrated, and even more customizable chips made from innovative materials with higher levels of quality control. 3D-printed microfluidics offers advantages such as rapid production, cost-effectiveness, and accurate design of a wide range of goods, including geometrically complex devices.

Covid-19 Impact Analysis:

The outbreak of COVID-19 and the subsequent extent of the lockdown have impacted the microfluidics market across the globe. As the Covid-19 crisis continues, many global industrial manufacturing companies are facing challenging times including production shutdowns, transportation, supply chain disruptions, cost increases, and workforce disruptions, which have several negative impacts on the global microfluidics industry in terms of revenue.

Driving Factors:

Advantages such as accessibility, portability, ease of operation, and shorter process time compared to conventional methods of diagnosis are driving rapid adoption of microfluidic POC testing, and the trend is projected to continue during the forecast period. Additionally, the increasing prevalence of lifestyle-related and infectious diseases, rising preference for home healthcare POC testing, and use during medical emergencies in hospitals for rapid diagnosis and decision-making are predicted to drive market revenue growth.

Research and development in microfluidics technology-based products involve high costs while financial support is limited. This has posed a major challenge to the growth of the global market. However, the lengthy clinical trial process for testing devices and chips adds to the long gestation period for research and development activities. Furthermore, the research sector of the healthcare industry in developing countries is undergoing rapid changes. Inadequacy research infrastructure in the healthcare sector in emerging markets may restrain the growth of the global market.

Key Market Players:

  • Danaher Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific 
  • PerkinElmer Inc.
  • Illumina, Inc.
  • Fluidigm Microfluidics
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche 
  • Abbott Laboratories
  • Fluigent SA
  • Idex Corporation
  • Qiagen
  • Parker-Hannifin Corporation
  • Camozzi Automation Spa Società Unipersonale
  • Aignep S.P.A.
  • SMC Corporation
  • Gems Sensors and Control
  • Dolomite Microfluidics
  • Cellix Ltd. 
  • Elveflow 
  • MicroLiquid
  • Microfluidic ChipShop
  • Micronit Microtechnologies 

Market Segmentation:

The global microfluidics market is segmented by material, product type, by application, and region.

By Material

On the basis of material the market is segmented into, glass, silicone, polymer, and others.

Polymers are preferred because of their low cost and well-established manufacturing processes. Poly (dimethylsiloxane) (PDMS) is in demand among these materials because it is easy to prototype with soft lithography and the material is gas-permeable, biocompatible, and transparent.

By Product

On the basis of product the market is segmented into, Microfluidic Components such as Flow and pressure sensors, Micropumps, Microneedles, Microfluidic chips, and other components.

The microfluidic chips segment accounted for a substantial revenue share in 2021. Highly interconnected microfluidic chips are portable, and compact, and require only a few reagents for early detection purposes. Altogether, microfluidic chips require less time than conventional medical identification devices, making them ideal for quick identification in locations where medical resources are not well developed.

By Application

On the basis of application the market is segmented into, pharmaceutical and biotechnology research, drug delivery systems, Point-of-Care Testing (POCT) diagnostics, clinical diagnostics, and others.

The Point-of-Care Testing (POCT) Diagnostics segment had the largest revenue share in 2021. Microfluidic-based POCT devices are generally employed for chemistry, molecular biology, and biochemical investigations, a major factor driving the growth of this segment.

Regional Analysis:

The global microfluidics market is categorized into regions such as Latin America, North America, Europe, Asia-pacific, the Middle East, and Africa.

The North American region holds the largest market share and is projected to continue its dominance during the forecast period. For example, this is attributed to better reimbursement policies as well as a well-established healthcare system and higher adoption rates of advanced therapies among the population. In relation to massive budget restrictions for research and development, particularly in the U.S. microfluidics in the U.S. is growing at a meteoric speed.

Report Coverage: 

Market Segmentation:

By Material

  • Glass
  • Silicone
  • Polymer
  • Others

By Product Type

  • Microfluidic Components
  • Flow and pressure sensors
  • Micropumps
  • Microneedles
  • Microfluidic chips
  • Others

??By Application

  • Pharmaceutical and biotechnology research
  • Drug delivery systems
  • Point-of-Care Testing (POCT) diagnostics,
  • Clinical diagnostics
  • Other

By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...